Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00129155
Status:
UNKNOWN
Last Update Posted:
2007-10-04
First Post:
2005-08-09
Brief Title:
MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
Sponsor:
Hospices Civils de Lyon
Organization:
Hospices Civils de Lyon
Study Overview
Official Title:
Unrelated Reduced Intensity Conditioning With Treosulfan for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies
Status:
UNKNOWN
Status Verified Date:
2007-10
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this study treosulfan is evaluated for conditioning in allogenic stem cell transplantation The procedure and the follow-up are the same as in standard allogenic transplant
The donor is unrelated identical HLA The graft is haematological peripheral blood stem cell
The conditioning with reduced intensity is fludarabine from day -6 to day -2 treosulfan from day -6 to day -4 and thymoglobuline from day -2 to day -1
The donor is unrelated identical HLA The graft is haematological peripheral blood stem cell
The conditioning with reduced intensity is fludarabine from day -6 to day -2 treosulfan from day -6 to day -4 and thymoglobuline from day -2 to day -1
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None